Observations placeholder
Xeloda
Identifier
020381
Type of Spiritual Experience
Number of hallucinations: 86
Background
A description of the experience
Capecitabine (INN) (Xeloda, Roche) is an orally-administered chemotherapeutic agent used in the treatment of numerous cancers. Capecitabine is a prodrug that is enzymatically converted to 5-fluorouracil (5-FU) in the body
Adverse effects
Adverse effects by frequency:Very common (>10% frequency)
- Appetite loss
- Diarrhea
- Vomiting
- Nausea
- Stomatitis
- Abdominal pain
- Fatigue
- Weakness
- Hand-foot syndrome
- Oedema
- Fever
- Pain
- Headache
- Hair loss
- Dermatitis
- Indigestion
- Shortness of breath
- Eye irritation
- Myelosuppression
On Dec, 28, 2016 27,913 people reported to have side effects when taking Xeloda.
Among them, 86 people (0.31%) have Hallucination
Time on Xeloda when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 57.89% | 31.58% | 10.53% | 0.00% | 0.00% | 0.00% | 0.00% |
Age of people who have Hallucination when taking Xeloda :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 5.17% | 3.45% | 13.79% | 77.59% |
On Feb, 16, 2016: 18,066 people reported to have side effects when taking Xeloda. Among them, 2,000 people (11.07%) have Death.
Time on Xeloda when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 41.91% | 41.91% | 8.67% | 7.51% | 0.00% | 0.00% | 0.00% |
Age of people who have Death when taking Xeloda :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.09% | 0.00% | 0.35% | 4.00% | 13.65% | 25.22% | 56.70% |
Top conditions involved for these people :
- Breast cancer (285 people, 14.25%)
- Breast cancer metastatic (152 people, 7.60%)
- Metastases to bone (101 people, 5.05%)
- Colon cancer (75 people, 3.75%)
- Colorectal cancer metastatic (74 people, 3.70%)